SELLAS Life Sciences Group, Inc. (SLS) EPS by Year
SLS
SELLAS Life Sciences Group, Inc. lost $0.25 per diluted share in fiscal year 2025. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $0.21 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters SELLAS Life Sciences Group, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.25
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
SLS EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was SELLAS Life Sciences Group, Inc.'s diluted earnings per share in fiscal year 2025?
SELLAS Life Sciences Group, Inc. lost $0.25 per diluted share in fiscal year 2025.
What is SELLAS Life Sciences Group, Inc.'s diluted earnings per share over the last twelve months?
SELLAS Life Sciences Group, Inc. (SLS) reported a loss of $0.21 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was SELLAS Life Sciences Group, Inc.'s diluted earnings per share in the most recent quarter?
SELLAS Life Sciences Group, Inc. (SLS) reported -$0.05 in diluted earnings per share in Q2 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what SELLAS Life Sciences Group, Inc. (SLS) reported on that line in every period on record.
